Interim Results from the CATNON Trial (EORTC Study 26053-22054) of Treatment with Concurrent and Adjuvant Temozolomide for 1p/19q Non-Co-deleted Anaplastic Glioma: a Phase 3, Randomised, Open-Label Intergroup Study Martin J. van den Bent , C. Mircea S. Tesileanu , Wolfgang Wick , Marc Sanson , Alba Ariela Brandes , Paul M. Clement , Sarah Erridge , Michael A. Vogelbaum , Anna K. Nowak , Jean Francais Baurain , Warren P. Mason , Helen Wheeler , Olivier L. Chinot , Sanjeev Gill , Matthew Griffin , Leland Rogers , Walter Taal , Roberta Ruda , Michael Weller , Catherine McBain , Jaap Reijneveld , Roelien H. Enting , Francesca Caparrotti , Thierry Lesimple , Susan Clenton , Anja Gijtenbeek , Elizabeth Lim , Ulrich Herrlinger , Peter Hau , Frederic Dhermain , Iris de Heer , Kenneth Aldape , Robert B. Jenkins , Hendrikus Jan Dubbink , Johan M. Kros , Pieter Wesseling , Sarah Nuyens , Vassilis Golfinopoulos , Thierry Gorlia , Pim French , Brigitta G. Baumert The Lancet Oncology（2021）
AI 理解论文
溯源树
样例
